Kopin: Q2 Earnings Snapshot
On a per-share basis, the Westborough, Massachusetts-based company said it had a loss of 3 cents.
The maker of wearable technologies posted revenue of $8.5 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KOPN at https://www.zacks.com/ap/KOPN
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
21 minutes ago
- Business Wire
NIU Invest Completes Acquisition of Majority Stake in Critical Metals
LONDON--(BUSINESS WIRE)--NIU Invest SE (NIU), headed by Austrian investor Cevdet Caner, completed its subscription for new Ordinary Shares of in Critical Metals PLC (Critical Metals) giving NIU an aggregate of 61,402,390 new Ordinary Shares, representing a majority 60.34% stake in the company. Critical Metals has a 70% stake in the Molulu Project, a cobalt and copper mining asset near Lubumbashi, in the Democratic Republic of Congo (DRC). The Molulu Project was previously mined by artisanal miners, and Critical Metals acquired the project in September 2022. Critical Metals plans to further develop and expand the Molulu Project's mining operations to realize the asset's full value. Caner stated, 'We are thrilled to complete this acquisition in the Democratic Republic of Congo and begin work on growing the operation and accelerating local development.' NIU is a leading Europe and US-based investment company focused on entrepreneurship and value creation, with the goal of becoming a fully integrated mining investor and operator with assets across North America, Latin America, Africa, and Europe. Austrian entrepreneur Cevdet Caner has invested in the mining and property sectors for over two decades. NIU plans to make further mining acquisitions in 2025, building a diverse portfolio of critical assets that drive long-term growth and align with the global demand for key inputs to advanced industries and cutting-edge technologies.
Business Wire
21 minutes ago
- Business Wire
AVF and ErgoAV Merge to Expand Innovative AV Accessories and Mounting Solutions
SHROPSHIRE, England--(BUSINESS WIRE)--Renowned British pioneer of AV mounting solutions AVF and fast-growing AV accessories and ergonomics brand ErgoAV today announced their merger, marking a momentous milestone and paving the way for continued growth and innovation for both companies. Consumers in global markets now benefit from an even broader choice of AV solutions and accessories, as both brands will bring in each other's products to their primary markets. AVF is an established industry leader in TV wall mounts, TV stands, and a wide range of AV furniture. Founded in 1977, the company has since become one of the largest AV mount and furniture brands in the UK. 'AVF is excited to join forces with ErgoAV, which will significantly expand our portfolio for both retail and commercial channels,' said Simon West, Managing Director of AVF. US-based ErgoAV has been building a name for itself since late 2022 with its innovative and ergonomically designed TV mounts, AV furniture, and smart office solutions—all by a team of known industry veterans with multi-decades of experience. ErgoAV is the US subsidiary of parent company Bestqi, one of the world's largest TV mount manufacturers, selling over five million units annually. The company had acquired AVF in June 2025, with the goal to enhance both brands' AV and office product offerings through combined expertise and leveraging Bestqi's R&D and manufacturing capabilities. 'The AVF, ErgoAV and Bestqi teams have collectively sold over 100 million TV mounts worldwide,' Henry Lyu, CEO of ErgoAV and Bestqi, shared. 'By merging ergonomics, smart home solutions, and thoughtful design, we aim to enhance every space with comfort, style, and next-generation innovation.' AVF and ErgoAV will retain their distinct brand identities while introducing each other's AV solutions, accessories, and furniture to the global market. This strategic synergy expands consumer choices, delivering creative and versatile options for modern homes and smart work spaces. About ErgoAV Led by a respected team of industry veterans, ErgoAV offers an innovative, ergonomic take on TV mounts, AV solutions, and accompanying accessories and furniture by seamlessly uniting form and function. Designed to enhance viewing and working experiences in any setup, whether home or office, ErgoAV's products optimize any space and provide endless possibilities with layout and viewing flexibility. For more information, please visit About AVF Founded in 1977, AVF has grown to become a leading AV mount brand in the UK and one of the world's leading suppliers of TV wall mounts and stylish TV stands. The company is known for its products' strength, durability, ease of installation, and design—all of which are continuously improved on and upgraded to align with market trends and user needs. For more information, please visit
Yahoo
36 minutes ago
- Yahoo
What Are Wall Street Analysts' Target Price for Hologic Stock?
Marlborough, Massachusetts-based Hologic, Inc. (HOLX) develops, manufactures, and supplies diagnostic products, imaging systems, and surgical products for women's health, helping in the early detection and treatment of diseases worldwide. With a market cap of $15.1 billion, Hologic operates through Diagnostics, Breast Health, GYN Surgical, and Skeletal Health segments. The company has significantly underperformed the broader market over the past year. HOLX stock has declined 15.4% over the past 52 weeks and 4.3% on a YTD basis, lagging behind the S&P 500 Index's ($SPX) 19% surge over the past year and 10% returns in 2025. More News from Barchart Why This Cannabis Penny Stock Could Be Wall Street's Next Meme Trade Breakout Peter Thiel-Backed Bullish Is About to IPO. Should You Buy BLSH Stock? Apple Stock Is Gaining Momentum, Is AAPL Stock a Buy? Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! Narrowing the focus, Hologic has also underperformed the industry-focused iShares U.S. Medical Devices ETF's (IHI) 10.3% gains over the past 52 weeks and 5.9% returns in 2025. While Hologic has underperformed the broader market over the past year, it has observed significant gains in recent months. Its stock prices have shot up more than 20% in the past three months alone. Further, HOLX stock gained 2.8% in the trading session following the release of its better-than-expected Q3 results on Jul. 30. The company's topline for the quarter inch up 1.2% year-over-year to $1.02 billion, surpassing the consensus estimates by 1.7%. Moreover, its adjusted EPS grew by 1.9% to $1.08, coming ahead of the management's guidance range and beating the Street's expectations by 2.9%. For the full fiscal 2025, ending in September, analysts expect Hologic to deliver an adjusted EPS of $4.24, up 3.9% year-over-year. The company has a mixed earnings surprise history. While it missed the Street's bottom-line estimates once over the past four quarters, it surpassed the projections on three other occasions. The stock has a consensus 'Moderate Buy' rating overall. Of the 19 analysts covering the stock, opinions include six 'Strong Buys,' two 'Moderate Buys,' and 11 'Holds.' This configuration is slightly more optimistic than two months ago, when five analysts gave 'Strong Buy' recommendations and only one analyst suggested a 'Moderate Buy' rating. On Aug. 6, RBC Capital analyst Conor McNamara upgraded HOLX from 'Sector Perform' to 'Outperform' and raised the price target from $72 to $87. As of writing, Hologic's mean price target of $73 suggests a modest 5.8% upside potential from current price levels. On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
